(Q40596034)

21 September 2017

title

Anti-tumor efficacy of human angiostatin using liver-mediated adeno-associated virus gene therapy (English)

1 reference

21 September 2017

0 references

Alshad S Lalani

1

1 reference

21 September 2017

Betty Chang

2

1 reference

21 September 2017

JianMin Lin

3

1 reference

21 September 2017

Scott S Case

4

1 reference

21 September 2017

Bo Luan

5

1 reference

21 September 2017

Wei-Wei Wu-Prior

6

1 reference

21 September 2017

Melinda VanRoey

7

1 reference

21 September 2017

Karin Jooss

8

1 reference

21 September 2017

publication date

1 January 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

9

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

56-66

1 reference

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Angiogenesis in cancer and other diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Adeno-associated virus site-specifically integrates into a muscle-specific DNA region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Tumour vasculature as a target for anticancer therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Advancing animal models of neoplasia through in vivo bioluminescence imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Unfulfilled promise of endostatin in a gene therapy-xenotransplant model of human acute lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Role of angiogenesis in tumor growth and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Clinical translation of angiogenesis inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Kinetics of recombinant adeno-associated virus-mediated gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Cancer therapy. Setbacks for endostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

pEF-BOS, a powerful mammalian expression vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Safety of adeno-associated virus gene therapy vectors: a current evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Adeno-associated virus vectors for gene therapy: more pros than cons?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Angiostatin binds ATP synthase on the surface of human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Angiostatin induces and sustains dormancy of human primary tumors in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Continuous intravascular secretion of endostatin in mice from transduced hematopoietic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Large-scale purification of recombinant human angiostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Angiostatin and endostatin: endogenous inhibitors of tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Production of clinical-grade recombinant adeno-associated virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Angiostatin and angiostatin-related proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

7 January 2021

Angiogenesis inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Suppression of tumor growth with recombinant murine angiostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Long-term expression of angiostatin suppresses metastatic liver cancer in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Vascular-specific growth factors and blood vessel formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.10.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2003.10.001

1 reference

21 September 2017

1 reference